ADIPOQ and cancer: Decreased serum adiponectin has been associated with higher risk of several types of cancer [123], including breast cancer, especially in postmenopausal women [124,125]; endometrial cancer, especially in younger women [126] with reported but controversial anti-cancer effects; gastric cancer [127]; prostate cancer [128]; and some types of myeloblastic leukemias [129].